Fibrinogen hillsborough: A novel γGly309Asp dysfibrinogen with impaired clotting

Blood

Volumn 99, Issue 10, 2002, Pages 3597-3601

  Mullin, Jennifer L ^a   Brennan, Stephen O ^a   Ganly, Peter S ^a   George, Peter M ^a  

^a CANTERBURY HEALTH LABORATORIES   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; BLOOD CLOTTING FACTOR 8; DODECYL SULFATE SODIUM; FIBRIN MONOMER; FIBRINOGEN; FIBRINOGEN HILLSBOROUGH; GLYCINE; THROMBIN; UNCLASSIFIED DRUG;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD CLOTTING DISORDER; CASE REPORT; CHEMICAL STRUCTURE; CODON; CONTROLLED STUDY; CROSS LINKING; DNA SEQUENCE; FIBRINOGEN BLOOD LEVEL; GENE MUTATION; HETEROZYGOSITY; HUMAN; ISOELECTRIC FOCUSING; MALE; MASS SPECTROMETRY; MOLECULAR WEIGHT; POLYACRYLAMIDE GEL ELECTROPHORESIS; POLYMERIZATION; PRIORITY JOURNAL; THROMBIN TIME; TRAFFIC ACCIDENT; TURBIDITY;

EID: 0037093093     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.10.3597     Document Type: Article

References (22)

1. Crystal structure of a 30 kDa C-terminal fragment from the γ chain of human fibrinogen
2. γ-γ cross-linking sites in human and bovine fibrin
3. Localization of the cross-linking site of GPRVVERHK in the γ-chain of human fibrinogen
4. The primary fibrin polymerization pocket: Three dimensional structure of a 30 kDa C-terminal γ chain fragment complexed with the peptide Gly-Pro-Arg-Pro
5. Crystal structures of fragment D from human fibrinogen and its crosslinked counterpart from fibrin
6. Crystal structures of fragments D and double-D from fibrinogen and fibrin
7. γ-chain dysfibrinogenemias: Molecular structure-function relationships of naturally occurring mutations in the γ chain of human fibrinogen
8. Aberrant hepatic processing causes removal of activation peptide and primary polymerization site from fibrinogen Canterbury (Aα20 Val→Asp)
9. Physiological studies of bovine fibrinogen. IV. Ultraviolet absorption and its relation to the structure of the molecule
10. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
11. Electrospray ionization analysis of human fibrinogen
12. Defective fibrinogen polymerization associated with a novel γ279Ala→Asp mutation
13. A simple method for DNA purification from peripheral blood
14. Size and density of fibrin fibers from turbidity
15. SWlSS-MODEL and the Swiss-Pdb Viewer: An environment for comparative protein modeling
16. 308→lle mutation
17. Fibrinogen Baltimore III: Congenital dysfibrinogenemia with a shortened γ-chain subunit
18. 308Asn→Lys (AAT→AAG) mutation associated with bleeding tendency
19. A lower-weight γ chain variant in a congenital abnormal fibrinogen (Kyoto)
20. Characterization of an apparently lower molecular weight γ-chain variant in fibrinogen Kyoto I. The replacement of γ-asparagine 308 by lysine which causes accelerated cleavage of fragment D1 by plasmin and the generation of a new plasmin cleavage site
21. Fibrinogen Matsumoto III: A variant with γ275Arg→Cys (CGC→TGC)-comparison of fibrin polymerization properties with those of Matsumoto I (γ364Asp→His) and Matsumoto II (γ308Asn→Lys)
22. 308→Lys) does not affect the binding of tPA and plasminogen to fibrin